LeMaitre Vascular logo

LeMaitre VascularNASDAQ: LMAT

Profile

Sector:

Healthcare

Country:

United States

IPO:

19 October 2006

Next earnings report:

27 February 2025

Last dividends:

15 August 2024

Next dividends:

21 November 2024
$2.32 B
-2%vs. 3y high
82%vs. sector
-24%vs. 3y high
83%vs. sector
-2%vs. 3y high
88%vs. sector
-2%vs. 3y high
80%vs. sector

Price

pre-market | 51 min ago
$103.28-$0.16(-0.15%)
$54.82 M$55.98 M
$54.82 M$11.14 M

Analysts recommendations

Institutional Ownership

LMAT Latest News

LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
seekingalpha.com03 November 2024 Sentiment: POSITIVE

LeMaitre continues to expand in the peripheral vascular disease market, with recent revenue gains driven by premium pricing and international growth. Its strong dividend growth of 14.3% this year and double-digit CAGR over the past five years are particularly appealing. With a high-margin, low-competition niche and accelerating geographic expansion, LeMaitre remains well-positioned for sustained growth.

LeMaitre to Participate at Upcoming Investor Conferences in November
globenewswire.com01 November 2024 Sentiment: POSITIVE

BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.

LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript
seekingalpha.com31 October 2024 Sentiment: NEUTRAL

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2024 Earnings Conference Call October 33, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer Dave Roberts - President Conference Call Participants Suraj Kalia - Oppenheimer Rick Wise - Stifel Brett Fishbin - KeyBanc Jason Wittes - Roth Danny Stauder - Citizens JMP Michael Petusky - Barrington Research Frank Takkinen - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Ross Osborn - Cantor Fritzgerald Operator Welcome to the LeMaitre Vascular Q3 2024 Financial Results Conference Call.

LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates
zacks.com31 October 2024 Sentiment: POSITIVE

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.33 per share a year ago.

LeMaitre Q3 2024 Financial Results
globenewswire.com31 October 2024 Sentiment: POSITIVE

BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance.

LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024
globenewswire.com15 October 2024 Sentiment: POSITIVE

BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy
zacks.com23 September 2024 Sentiment: POSITIVE

LeMaitre (LMAT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LeMaitre to Participate at Upcoming Investor Conferences in September
globenewswire.com27 August 2024 Sentiment: POSITIVE

BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September.

LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why
zacks.com06 August 2024 Sentiment: POSITIVE

LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LeMaitre Vascular (LMAT) Surpasses Q2 Earnings and Revenue Estimates
zacks.com01 August 2024 Sentiment: POSITIVE

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.37 per share a year ago.

  • 1(current)
  • 2
  • 3

What type of business is LeMaitre Vascular?

LeMaitre Vascular, Inc. is a medical equipment manufacturing company in the United States. Its products are used by vascular surgeons and specialist physicians in invasive procedures. The company offers angioscopes, fiber-optic catheters used for viewing the lumen of blood vessels; embolic catheters for removing clots from arteries or veins; occlusion catheters that temporarily block blood flow; perfusion catheters for temporary blood and other fluid perfusion into the vascular system; and thrombectomy catheters equipped with a silicone balloon for removing clots in the venous system. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

What sector is LeMaitre Vascular in?

LeMaitre Vascular is in the Healthcare sector

What industry is LeMaitre Vascular in?

LeMaitre Vascular is in the Medical Instruments & Supplies industry

What country is LeMaitre Vascular from?

LeMaitre Vascular is headquartered in United States

When did LeMaitre Vascular go public?

LeMaitre Vascular initial public offering (IPO) was on 19 October 2006

What is LeMaitre Vascular website?

https://www.lemaitre.com

Is LeMaitre Vascular in the S&P 500?

No, LeMaitre Vascular is not included in the S&P 500 index

Is LeMaitre Vascular in the NASDAQ 100?

No, LeMaitre Vascular is not included in the NASDAQ 100 index

Is LeMaitre Vascular in the Dow Jones?

No, LeMaitre Vascular is not included in the Dow Jones index

When was LeMaitre Vascular the previous earnings report?

No data

When does LeMaitre Vascular earnings report?

The next expected earnings date for LeMaitre Vascular is 27 February 2025